Drugs / Vusion
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | VUSION | — | 2006-02-16 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01118910 | Apr → Nov 2010 | intertrigo | Image Dermatology P.C. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01118910 ↗ |
| Route | Topical | “Vusion will be applied to areas of intertrigo” NCT01118910 ↗ |